Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

EISAI FARMACEUTICA UNIPESSOAL LDA.

NIF 507847660
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €895,418 27 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €895,418 27 contracts
A2 · Late Publication €2,056,675,829 504 contracts
Contract published to BASE more than 10 days after the signing date
LOW €2,056,675,829 504 contracts
A5 · Threshold Splitting €6,173,552 14 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €6,173,552 14 contracts
A6 · Low Competition €541,752 8 contracts
Only one bidder participated in a competitive procedure
MEDIUM €541,752 8 contracts
A9 · Price Overrun €111,926 1 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
HIGH €111,926 1 contracts
A9 · Abnormal Price Reduction €2,539,315,531 212 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €2,539,315,531 212 contracts
C3 · Missing Mandatory Fields €703,002 13 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €703,002 13 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

83
€252,918,680
36
€219,613,441
56
€200,346,483
9
€189,659,167
25
€156,265,985
17
€154,665,644
34
€133,312,693
10
€110,370,266
16
€103,693,961
10
€95,084,675
9
€91,333,017
141
€89,269,521
6
€88,666,854
13
€86,446,068
33
€81,931,551
30
€73,191,664
13
€71,796,434
8
€62,362,854
11
€50,587,980
3
€47,951,561
Page 1 of 2 · 37 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Price Overrun A9 · Abnormal Price Reduction C3 · Missing Mandatory Fields

Page 1 of 1 · 1 contracts

LENVATINIB CAPS
PT · 7797521 · Ajuste Direto Regime G...
A9 · Price Overrun A2 · Late Publication
€111,926 2021-02-08
Overview
Total Value Won
€2,561,052,111
Contracts Won
732
Score 24570 · CRITICAL RISK
NIF
507847660
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • S.U. [P-c15b]
    Gerente
    since 2026-04-06
  • Y.M. [P-74bf]
    Gerente
    since 2026-04-06
  • E.E. [P-55f1]
    Sócio
    since 2006-11-15
  • F.K. [P-585d]
    Gerente
    2009-03-09 → 2009-09-09
  • G.B. [P-0a3b]
    Gerente
    2013-03-13 → 2026-04-06
  • G.W. [P-3d08]
    Gerente
    2013-03-13 → 2017-08-22
  • G.B. [P-2c80]
    Gerente
    2009-09-09 → 2010-08-18
  • J.G. [P-aa48]
    Gerente
    2010-08-18 → 2010-09-20
  • K.M. [P-29da]
    Gerente
    2016-09-29 → 2019-06-21
  • M.S. [P-6ab1]
    Gerente
    2014-08-05 → 2016-09-29
  • M.N. [P-4208]
    Gerente
    2009-09-09 → 2013-05-14
  • N.C. [P-0d58]
    Gerente
    2016-09-29 → 2026-04-07
  • T.H. [P-9047]
    Gerente
    2009-09-09 → 2010-08-18
  • T.Y. [P-c49a]
    Gerente
    2010-08-18 → 2013-03-13
  • T.A. [P-fabd]
    Gerente
    2013-03-13 → 2014-08-05
  • T.A. [P-fabd]
    Gerente
    2019-06-21 → 2022-06-09
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned